Vernalis Share Discussion Threads

[fhmktg] 23/11/2017 09:05

Just read the Edison note which emphasises the need for clarity for CP07/08 resubmission.If they can show a clear timetable so that ALL the remaining developments will be ready for the next year's season, that could spark a revival in the forecasts.If there is any further delay VER could run out of cash in 2019 and disaster looms!

[fhmktg] 23/11/2017 08:56

14th December for the agm....fgs I hope we get some clarity on how Tris are dealing with the fda issues or the strategy looks doubtful.

[meijiman] 23/11/2017 08:48

A big negative is the level of cash burn ..with seemingly not much to show from it.
I shall have a read of the Edison note.

[chrisdgb] 23/11/2017 08:27

Edison price target yesterday 68p...........would be nice....

[bountyhunter] 14/11/2017 11:20

desperately in need of some positive news here to reverse the slump

[hvs] 14/11/2017 10:43

So you sold out and someone else kweeps buying.

Good move.

[romeike] 30/10/2017 12:06

I recently reduced my holding here by over 60% as the opportunity arose to swap out the funds into Shire, with its share price severely down for no good reason it makes a lot of sense to do so - far more certainty of a recovery and profits at Shire than here. And CEO Flemming O is leagues ahead of this no hoper Ian Garland at Vernalis.

Looks very much like Vernalis strategy is hostage to its partner Tris, with no control over what looks like an increasingly chaotic situation. Can only hope Vernalis is applying pressure but months on and still no word of progress. Strategy making less and less sense with ongoing cash burn at $20m but revenues just a few million, how can this ever make sense without more products hitting the market in a reasonable time.

[weber77] 27/10/2017 23:01

First post but thought this glassdoor review might give you a little insight in to tri pharma.

Pros
Mentally strengths you, so if you find yourself in a POW camp at some point - it will seem like a vacation...
Cons
I'm going to provide you with a realistic review of working at Tris Pharma, complete with actual facts (you know, those little pieces of knowledge that Tris fails to admit exist - like a Trump tax return). I served out my 3 year sentence and was finally released for early when the brainwashing and verbal beatings just stopped working. I don't know that I can describe in words what it is like to work for Tris, I would say it is something that needs to be experienced, but that's like saying one needs to experience drowning or burning alive. Sometimes you just have to believe its going to be unpleasant. Reading the past reviews, it is clear that the company has paid to have the positives ones written or more in line with Tris policy - forced employees to come to work on a federal holiday and write them for free. I do agree with the most recent review. This brings me to my first fact - turnover. Can you think of any other company that has a 90% plus turnover in management? and I'm talking senior management. These are successful people that have moved up the ranks at prestigious companies, some multiple billion dollar global organizations. For some reason, they just can't seem to or want to stay employed at Tris. Just so you don't think I'm making this up, here is just a partial list of the people who have come and gone at Tris over the last few years:
Chief Scientific Officer
Director of Finance
Director of Supply Chain
VP of Operations (1)
VP of Operations (2)
VP of Operations (3)
VP of Quality (1)
VP of Quality (2)
Chief Business Officer
Manager of Operations (1)
Manager of Operations (2)
Manager of Operations (3)
Director of Quality Assurance
Sr Manager of Compliance
Sr Manager of Quality Control
Supervisor Quality Control
Supervisor Quality Control (2)
VP of R&D (1)
VP of R&D (2)
Director of Method Development
VP of Regulatory
Sr. Manager of Regulatory
Manager of Regulatory
Manager of Packaging
At least 8 purchasing employees - in a total group size of 3
Director of product Development
VP of Sales
VP Business Develpment
Director of IT
Manager of IT
More operators, scientists, chemists, quality inspectors than I could possibly count.
Now this is not a comprehensive list, but I can assure you it is factual. Can you think of any other organization in the world that can turnover this number of management positions in 4 years and still be successful? Keep in mind the company only had 50 - 200 total people during this time. Of course you can't. It isn't possible and that's why Tris isn't successful anymore either.
Fact #2 - Sure things at Tris were going well for a while and the owner made a ton of money (fact #3 - check out the $10 million condo he bought last year in Miami, all while telling the employees that there is no money for raises or bonuses (again).

Fact #4 - Take a look at Tris' partner Vernallis' stock. Went from $25 to $18 because of the poor FDA inspection Tris just had and an FDA letter they received, where their product was not approved. This comes as no surprise when you have an owner that is just about getting product out the door rather than assuring it is quality product. Hence all the recent recalls.


Fact #5, #6, #7 - We have all seen foreign companies like this before and they always get what's coming to them. Tris is at that point. Tris is now in trouble with the FDA, its partners are not happy with them and will start leaving. The sales forces can't seem to get anything done and how can they with the shoe string budget they are given. Hard to sell $200 a bottle pills when you have to take customers to Bob's Big Boy for dinner. The worse employees will remain, the good ones have left or will leave. Talk to others in the pharmaceutical industry, they all know Tris and the CEO. Its like a red badge of courage to have put your time in and learned what not to do and how not to run a company. Soon they will have only the most incompetent people remaining and that will be the final straw in this long drawn out tragedy.... RIP

[romeike] 20/10/2017 14:07

Well, they claim they cannot say anything about this because this issue is with Tris and as a private company Tris is not obliged to share any more information than it wants to, and further Tris itself operates on the basis of saying as little as possible.

[fhmktg] 17/10/2017 09:22

Still no information on how the issues raised by the fda are going to be dealt with.Not good enough!

[romeike] 13/10/2017 13:42

Not so sure about that the sell is barely above the buy, but yeah, they'll do well if there is a return to 40p. Going to take some significant good news though.

The board promised to triple prescriptions on Txr over the last period, if it becomes clear early next year that that isn't likely to be the case then I really think it will be time for a new CEO and a review of strategy.

At the moment the big problem is the cash burn vs revenue. Even if they were to get Moxatag, Txr, CCP-07 and CCP-08 all earning revenues, would it be enough to cover even half the current cash burn?

Really I think they need to be earning at least 10 mil on Txr alone next period for their strategy to be viable.

[bantam175] 12/10/2017 17:21

Probably a shorter bottom fishing.

Did well whoever it was

[fhmktg] 12/10/2017 13:46

Somebody has faith, everything that comes for sale gets mopped up.

[romeike] 12/10/2017 12:38

I suspect an institutional investor lost patience with board and is dumping stock. Cannot see any rationale for a currently well funded business to go to the market while its share price is in the gutter.

[romeike] 12/10/2017 12:37

If it is it would show massive incompetence on the part of the board. They have 65 million or so in the bank, why fund raise when share price is rock bottom. What can be so urgent they have to fund raise now when they recently said they have plenty of cash and no debt and were reasonably confident they wouldn't need to raise more.

[bones698] 12/10/2017 12:32

Looks.like.a fund raising coming judging by the lack of news and share price fall just like agl and nano . Expect it to level off jut above the issue price imo . So far looks like it could be at 8p or possibly 5p . Usual share price reaction when the company goes to the city asking for money no other real explanation I can see

[chrisdgb] 12/10/2017 12:13

10p fund raising...........????????????

[meijiman] 09/10/2017 08:45

Is this worth buying? -priced almost like option money. Financially sound but massive cash burn. Any views from pharma expert?

[chrisdgb] 09/10/2017 08:30

Indeed, the big share holders need to get active with this one..........

[romeike] 02/10/2017 15:22

Healthcare up across the board today with one exception - Vernalis. Time for a certain Mr. Woodford to insist on regime change at Vernalis?

[romeike] 28/9/2017 11:27

Is the incompetent CEO really considering a capital raise with the share price at rock bottom? Of course he is, he only cares about keeping his snout in the trough.

[pugg1ey] 27/9/2017 12:32

brown envelopes all round for the directors and 'advisors'
brown pants for the shareholders

[romeike] 27/9/2017 12:02

SP here finding new lows as management fails to get to grips with major issues, fails to update shareholders with any good news and fails to revise its strategy.

Why is Ian Garland still CEO?

[bountyhunter] 17/9/2017 21:29

not quite sure what your point is hvs? was that suppose to be a dig at me?
(best ignored judging by previous posts)

[hvs] 16/9/2017 12:26

IDIOTS ABOUND

and this is a bit too vague for my liking, again missing a target date other than sometime in 2018..

lol !!!!!!

lol !!!!!!!!!!